SC Filed 2020-06-22 Event — SEC 0001387131-20-005869 →

GLAXOSMITHKLINE PLC → Theravance Biopharma, Inc. TBPH

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

13 transactions

10 buys · 3 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 5.31

4,306,471 shares short · -4.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $196K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-15	Farnum Rhonda	officer	Sale	3,329	$16.39	$55K
2026-06-15	Farnum Rhonda	officer	Sale	3,328	$16.38	$55K
2026-06-15	Farnum Rhonda	officer	Sale	6,657	$16.39	$109K
2026-06-12	Smaldone Alsup Laurie	director	Award	6,009	—	—
2026-06-12	Smaldone Alsup Laurie	director	Award	13,398	$16.64	$223K
2026-06-12	GRAY SUSANNAH	director	Award	6,009	—	—
2026-06-12	GRAY SUSANNAH	director	Award	13,398	$16.64	$223K
2026-06-12	MITCHELL DEAN J	director	Award	6,009	—	—
2026-06-12	MITCHELL DEAN J	director	Award	13,398	$16.64	$223K
2026-06-12	O'Connor Donal	director	Award	6,009	—	—
2026-06-12	O'Connor Donal	director	Award	13,398	$16.64	$223K
2026-06-12	PAKIANATHAN DEEPIKA	director	Award	6,009	—	—
2026-06-12	PAKIANATHAN DEEPIKA	director	Award	13,398	$16.64	$223K

Other 13D/G Filings on Theravance Biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2023-08-14	SC	Weiss Asset Management LP	—	—	view →
2022-09-20	SC	GSK PLC	—	—	view →
2022-02-10	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-02-27	SC	GLAXOSMITHKLINE PLC	—	—	view →
2019-04-18	SC	GLAXOSMITHKLINE PLC	—	—	view →

Other Filings by GLAXOSMITHKLINE PLC

Filed	Form	Issuer	Stake	Shares
2023-10-10	SC	Haleon plc HLNCF	—	—	view →
2022-11-14	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2022-09-20	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2022-02-10	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2021-09-16	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2021-09-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-04-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-04-08	SC	Pandion Therapeutics, Inc.	—	—	view →
2021-02-12	SC	Innoviva, Inc. INVA	—	—	view →
2020-12-07	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-12-07	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2020-10-01	SC	Principia Biopharma Inc.	—	—	view →
2020-06-29	SC	Morphic Holding, Inc.	—	—	view →
2020-06-04	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-02-27	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2019-04-18	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2018-07-17	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2018-04-10	SC	Innoviva, Inc. INVA	—	—	view →
2018-02-13	SC	HTG MOLECULAR DIAGNOSTICS, INC	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →